Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19

被引：0
|
作者：
Alberto Papi
Renee D. Stapleton
Paul M. Shore
Mihai Alexandru Bica
Younan Chen
Michael Larbig
Tobias Welte
机构：
[1] University of Ferrara,Respiratory Department
[2] University of Vermont,Pulmonary and Critical Care Medicine
[3] CSL Behring,Clinical Development
[4] CSL Behring Innovation,Global Clinical Safety and Pharmacovigilance
[5] CSL Behring,Biostatistics
[6] CSL Behring AG,Clinical Development
[7] Hannover Medical School,Department of Pulmonary and Infectious Diseases
来源：
Lung | 2023年 / 201卷
关键词：
COVID-19; Critically ill patients; Inflammation; Respiratory disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：159 / 170
页数：11
相关论文
共 50 条
  • [31] Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
    Qiuyu Li
    Cheng Cui
    Fei Xu
    Jianping Zhao
    Nan Li
    Haichao Li
    Tianbing Wang
    Hua Zhang
    Na Liu
    Yudong Wei
    Xiaoye Niu
    Yan Xu
    Jianping Dong
    Xueting Yao
    Xiaohong Wang
    Yahong Chen
    Haiyan Li
    Chunli Song
    Jie Qiao
    Dongyang Liu
    Ning Shen
    [J]. Science China Life Sciences, 2021, 64 (04) : 660 - 663
  • [32] Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
    Qiuyu Li
    Cheng Cui
    Fei Xu
    Jianping Zhao
    Nan Li
    Haichao Li
    Tianbing Wang
    Hua Zhang
    Na Liu
    Yudong Wei
    Xiaoye Niu
    Yan Xu
    Jianping Dong
    Xueting Yao
    Xiaohong Wang
    Yahong Chen
    Haiyan Li
    Chunli Song
    Jie Qiao
    Dongyang Liu
    Ning Shen
    [J]. Science China Life Sciences, 2021, 64 : 660 - 663
  • [33] A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19
    Kharazmi, Amir Behnam
    Moradi, Omid
    Haghighi, Mehrdad
    Kouchek, Mehran
    Manafi-Rasi, Alireza
    Raoufi, Masoomeh
    Shoaei, Simin Dokht
    Hadavand, Fahimeh
    Nabavi, Mahmood
    Miri, Mir Mohammad
    Salarian, Sara
    Shojaei, Seyedpouzhia
    Khalili, Shayesteh
    Sistanizad, Mohammad
    Sadeghi, Setayesh
    Karagah, Amirhossein
    Asgari, Saemeh
    Jaffaraghaei, Morteza
    Araghi, Shahram
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (02) : 201 - 208
  • [34] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
    Nurullah Okumuş
    Neşe Demirtürk
    Rıza Aytaç Çetinkaya
    Rahmet Güner
    İsmail Yaşar Avcı
    Semiha Orhan
    Petek Konya
    Bengü Şaylan
    Ayşegül Karalezli
    Levent Yamanel
    Bircan Kayaaslan
    Gülden Yılmaz
    Ümit Savaşçı
    Fatma Eser
    Gürhan Taşkın
    [J]. BMC Infectious Diseases, 21
  • [35] Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study
    Bartoletti, Michele
    Marconi, Lorenzo
    Scudeller, Luigia
    Pancaldi, Livia
    Tedeschi, Sara
    Giannella, Maddalena
    Rinaldi, Matteo
    Bussini, Linda
    Valentini, Ilaria
    Ferravante, Anna Filomena
    Potalivo, Antonella
    Marchionni, Elisa
    Fornaro, Giacomo
    Pascale, Renato
    Pasquini, Zeno
    Puoti, Massimo
    Merli, Marco
    Barchiesi, Francesco
    Volpato, Francesca
    Rubin, Arianna
    Saracino, Annalisa
    Tonetti, Tommaso
    Gaibani, Paolo
    Ranieri, Vito Marco
    Viale, Pierluigi
    Cristini, Francesco
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (01) : 105 - 111
  • [36] Efficacy and tolerability of bevacizumab in patients with severe Covid-19
    Jiaojiao Pang
    Feng Xu
    Gianmarco Aondio
    Yu Li
    Alberto Fumagalli
    Ming Lu
    Giuseppe Valmadre
    Jie Wei
    Yuan Bian
    Margherita Canesi
    Giovanni Damiani
    Yuan Zhang
    Dexin Yu
    Jun Chen
    Xiang Ji
    Wenhai Sui
    Bailu Wang
    Shuo Wu
    Attila Kovacs
    Miriam Revera
    Hao Wang
    Xu Jing
    Ying Zhang
    Yuguo Chen
    Yihai Cao
    [J]. Nature Communications, 12
  • [37] Efficacy and tolerability of bevacizumab in patients with severe Covid-19
    Pang, Jiaojiao
    Xu, Feng
    Aondio, Gianmarco
    Li, Yu
    Fumagalli, Alberto
    Lu, Ming
    Valmadre, Giuseppe
    Wei, Jie
    Bian, Yuan
    Canesi, Margherita
    Damiani, Giovanni
    Zhang, Yuan
    Yu, Dexin
    Chen, Jun
    Ji, Xiang
    Sui, Wenhai
    Wang, Bailu
    Wu, Shuo
    Kovacs, Attila
    Revera, Miriam
    Wang, Hao
    Jing, Xu
    Zhang, Ying
    Chen, Yuguo
    Cao, Yihai
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [38] Treatment options for patients with severe COVID-19
    Morishita, Momoko
    Hojo, Masayuki
    [J]. GLOBAL HEALTH & MEDICINE, 2023, 5 (02): : 99 - 105
  • [39] Efficacy and Safety of Tocilizumab Treatment in Tunisian Critically Ill COVID-19 Patients
    Bahrini, Khadija
    Larbi, Hamza Ben Cheikh
    Ben Azaiez, Mouna
    Stambouli, Nejla
    Zakraoui, Mohamed
    Boughariou, Sana
    Yousfi, Mohamed Ali
    Labbene, Iheb
    Daiki, Mayssa
    Gharsallah, Hedi
    Romdhani, Chihebeddine
    Ferjani, Mustapha
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2024, 2024
  • [40] Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19
    Nagasawa, Ryo
    Niwa, Takashi
    Hagiwara, Eri
    Oda, Tsuneyuki
    Yamada, Sho
    Okuda, Ryo
    Baba, Tomohisa
    Komatsu, Shigeru
    Kaneko, Takeshi
    Ogura, Takashi
    [J]. INTERNAL MEDICINE, 2023, 62 (21) : 3125 - 3130
12345